Provided by Tiger Trade Technology Pte. Ltd.

Autolus Therapeutics PLC

2.31
-0.0400-1.70%
Pre-market: 2.380.0695+3.01%08:24 EDT
Volume:1.48M
Turnover:3.45M
Market Cap:614.79M
PE:-2.19
High:2.38
Open:2.31
Low:2.30
Close:2.35
52wk High:2.58
52wk Low:1.18
Shares:266.14M
Float Shares:118.00M
Volume Ratio:1.08
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0526
EPS(LYR):-1.0804
ROE:-133.00%
ROA:-25.44%
PB:8.21
PE(LYR):-2.14

Loading ...

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
Mar 27

Autolus Therapeutics PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 27

Autolus Highlights AUCATZYL Launch and Pipeline Advancements

TIPRANKS
·
Mar 27

Autolus Therapeutics FY2025 net loss widens 30.3% to $(288) million; revenue rises to $75 million

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 27

Autolus Therapeutics PLC expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
Mar 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

Autolus Therapeutics plc Director Ryan Richardson Files Initial Beneficial Ownership Statement

Reuters
·
Mar 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

Autolus Therapeutics plc files initial beneficial ownership statement for U.S. CCO and Country General Manager Cintia Piccina

Reuters
·
Mar 19

Autolus Therapeutics files Form 3 initial beneficial ownership statement for Director Rao Madduri Ravin

Reuters
·
Mar 19

Autolus Therapeutics files Form 3 initial beneficial ownership statement for Director Michael W Bonney

Reuters
·
Mar 19

Autolus Therapeutics director Linda Bain files initial beneficial ownership statement

Reuters
·
Mar 19

Autolus Therapeutics plc Director John E. Berriman Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Autolus Therapeutics plc files Form 3 as SVP, Legal Affairs and GC Alex Driggs reports beneficial ownership

Reuters
·
Mar 19

Autolus Therapeutics plc CTO Suzette Neville Miranda files initial beneficial ownership statement

Reuters
·
Mar 19

European Equities Traded in US as ADRs Fall in Wednesday Trading

MT Newswires Live
·
Mar 18

Autolus Therapeutics PLC expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
Mar 16

European Equities Traded in US as ADRs Slump in Thursday Trading

MT Newswires Live
·
Mar 12

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

MT Newswires Live
·
Mar 11